Belzeaux, Raoul
Lin, Rixing
Turecki, Gustavo
Funding for this research was provided by:
Canadian Institutes of Health Research (FRN148374, FRN141899, FRN93775, FRN11260, FRN119429, FRN119430)
National Institutes of Health (1R01DA033684)
Fonds de Recherche du Québec - Santé (Quebec Network on Suicide, Mood Disorders and Related Disorders)
Pfizer (Investigator-Initiated Research Grant)
Article History
First Online: 13 March 2017
Compliance with Ethical Standards
:
: GT is supported by grants from the Canadian Institutes of Health Research (FRN: 148374, 141899, 93775, 11260, 119429, and 119430), from the US National Institutes of Health (1R01DA033684), by the Fonds de Recherche du Québec—Santé through the Quebec Network on Suicide, Mood Disorders and Related Disorders, and through an investigator-initiated research grant from Pfizer.
: Raoul Belzeaux, Rixing Lin and Gustavo Turecki have no conflicts of interest.